Sustained weight loss exceeding 100 kg with sequential incretin-based therapy in Prader-Willi syndrome
JCEM Case Reports
- Sequential incretin-based therapy
- Dulaglutide
- GLP-1 and incretin signalling
- Prader-Willi syndrome
- Obesity
- Humans
The paper
Yovera-Aldana M, Manrique-Hurtado H, Umpierrez GE
JCEM Case Reports · 16 Sep 2026
